Effect of Staphylococcus and Neisseria Tablets on Clinical Outcome Among Patients With Chronic Obstructive Pulmonary Disease

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

February 28, 2025

Study Completion Date

July 31, 2025

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Staphylococcus and Neisseria Tablets

Staphylococcus and Neisseria tablets is used as an adjuvant treatment drug for respiratory disease in acute attack period, such as chronic tracheitis, bronchitis and various types of colds. It has been proved to effectively shorten the course of disease. In this study, Staphylococcus and Neisseria tablets will be administered with 4 tablets each time and 3 times a day, and treatment period ranges from 3 to 6 months according to clinicians.

Trial Locations (1)

100191

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER